Introduction
Results
GCAP1 and GCAP2 are expressed in mouse cones

GCAP1 and GCAP2 regulate the kinetics and sensitivity of mouse cone phototransduction

Genotype | rmax | tp | ti | I½ | I0 | n |
---|---|---|---|---|---|---|
μV | ms | ms | photons μm−2 | photons μm−2 | ||
WT | 144 ± 15 | 53 ± 1 | 51 ± 0.1 | 3,200 ± 130 | 14,500 ± 3,000 | 1.0 ± 0.1 |
GCAPs−/− | 156 ± 26 | 76 ± 3* | 90 ± 9* | 1,900 ± 150* | 3,600 ± 800* | 1.5 ± 0.03* |
GCAP1−/− | 135 ± 6 | 66 ± 3* | 64 ± 4*† | 2,100 ± 320* | 6,900 ± 900* | 1.0 ± 0.02† |
GCAP2−/− | 125 ± 18 | 52 ± 2† | 49 ± 2† | 4,000 ± 450† | NA | NA |
GCAP2 promotes cGMP synthesis in low Ca2+ in mouse cones

GCAP2 contributes to mouse cone light adaptation in bright background light

GCAP1 and GCAP2 compete for activation of RetGC1 in low Ca2+

Discussion
Ca2+-dependent regulation of cGMP synthesis by GCAP2 in mouse cone photoreceptors
The role of GCAP1 and GCAP2 in cone phototransduction and light adaptation
Experimental procedures
Ethical approval
Animals
Single-cell immunohistochemistry
Ex vivo electroretinography
where rmax is the maximal saturated response amplitude, IF is flash intensity, and I½ is the light intensity (in photons μm−2) required to elicit a half-maximal response. A modified Weber-Fechner function was fitted to light adaptation data.
where SF is the sensitivity of cones to a flash of light (IF that elicits r < 0.2rmax) defined as r/IF, SF,D is the sensitivity in darkness, I is the background light intensity (in photons μm−2 s−1), I0 is the background light intensity in which SF = 0.5SF,D, and n is a factor determining the steepness of the adaptation curve.
where r0 is peak amplitude measured at td, A is amplitude measured from the peak to the steady-state plateau of the step response, A1 is the fraction of recovery covered by the time constant τ1, and (A − A1) is the fraction of the recovery covered by the time constant τ2.
Biochemical model of RetGC1 activation by GCAP2
where KCa = 50 nm is the apparent dissociation constant of Ca2+ from GCAP2. We model the activation of RetGC1 by GCAP2 by assuming that only Ca2+-free GCAP2 can activate the RetGC1.
where KGC1 = 1.25 μm and GC1total = 3.2 μm. Cyclase activity (α; in μm s−1) can be calculated as follows.
if we assume that GTP (the substrate) ≫ Km(GTP-GC) (dissociation constant of the GTP from RetGC1). We assume that the basal RetGC1 activity kn1 = 2.6 s−1 and for the activated RetGC1 ks1 = 33 s−1 (
where β = 4.1 s−1 is the spontaneous cGMP hydrolysis activity of rod PDE in darkness (
where Jmax is the CNG channel current at high [cGMP]. Assuming that [Ca2+] is 250 nm in a dark-adapted mouse cone outer segment under normal extracellular Ca2+ and declines to 25 nm during our low-Ca2+ exposure (see above), as low as a 0.1 μm total concentration of GCAP2 in the cone outer segment is predicted to cause a 4.4-fold increase of JcG when switched from normal (1.2 mm) Ca2+ to low Ca2+.
Expression and purification of GCAPs
RetGC assays
Author contributions
Acknowledgments
References
- Purification and physiological evaluation of a guanylate cyclase activating protein from retinal rods.Proc. Natl. Acad. Sci. U.S.A. 1994; 91 (7909609): 4014-4018
- Guanylyl cyclase activating protein. A calcium-sensitive regulator of phototransduction.J. Biol. Chem. 1995; 270 (7665624): 22029-22036
- Molecular cloning and characterization of retinal photoreceptor guanylyl cyclase-activating protein.Neuron. 1994; 13 (7520254): 395-404
- Highly cooperative feedback control of retinal rod guanylate cyclase by calcium ions.Nature. 1988; 334 (2455233): 64-66
- Cloning, sequencing, and expression of a 24-kDa Ca2+-binding protein activating photoreceptor guanylyl cyclase.J. Biol. Chem. 1995; 270 (7559656): 25200-25206
- The human photoreceptor membrane guanylyl cyclase, RetGC, is present in outer segments and is regulated by calcium and a soluble activator.Neuron. 1994; 12 (7912093): 1345-1352
- Diversity of guanylate cyclase-activating proteins (GCAPs) in teleost fish: characterization of three novel GCAPs (GCAP4, GCAP5, GCAP7) from zebrafish (Danio rerio) and prediction of eight GCAPs (GCAP1–8) in pufferfish (Fugu rubripes).J. Mol. Evol. 2004; 59 (15486694): 204-217
- Characterization of retinal guanylate cyclase-activating protein 3 (GCAP3) from zebrafish to man.Eur. J. Neurosci. 2002; 15 (11860507): 63-78
- The localization of guanylyl cyclase-activating proteins in the mammalian retina.Invest. Ophthalmol. Vis. Sci. 1998; 39 (9620085): 1243-1250
- Gene array and expression of mouse retina guanylate cyclase activating proteins 1 and 2.Invest. Ophthalmol. Vis. Sci. 1998; 39 (9579466): 867-875
- Autosomal dominant cone dystrophy caused by a novel mutation in the GCAP1 gene (GUCA1A).Mol. Vis. 2005; 11 (15735604): 143-151
- A novel mutation (I143NT) in guanylate cyclase-activating protein 1 (GCAP1) associated with autosomal dominant cone degeneration.Invest. Ophthalmol. Vis. Sci. 2004; 45 (15505030): 3863-3870
- A novel GCAP1 missense mutation (L151F) in a large family with autosomal dominant cone-rod dystrophy (adCORD).Invest. Ophthalmol. Vis. Sci. 2005; 46 (15790869): 1124-1132
- A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal dominant cone dystrophy pedigree mapping to a new locus on chromosome 6p21.1.Hum. Mol. Genet. 1998; 7 (9425234): 273-277
- Autosomal dominant cone and cone-rod dystrophy with mutations in the guanylate cyclase activator 1A gene-encoding guanylate cyclase activating protein-1.Arch. Ophthalmol. 2001; 119 (11146732): 96-105
- Identification and functional consequences of a new mutation (E155G) in the gene for GCAP1 that causes autosomal dominant cone dystrophy.Am. J. Hum. Genet. 2001; 69 (11484154): 471-480
- GCAP1 (Y99C) mutant is constitutively active in autosomal dominant cone dystrophy.Mol. Cell. 1998; 2 (9702199): 129-133
- Constitutive activation of photoreceptor guanylate cyclase by Y99C mutant of GCAP-1. Possible role in causing human autosomal dominant cone degeneration.J. Biol. Chem. 1998; 273 (9651312): 17311-17314
- Role of guanylate cyclase-activating proteins (GCAPs) in setting the flash sensitivity of rod photoreceptors.Proc. Natl. Acad. Sci. U.S.A. 2001; 98 (11493703): 9948-9953
- Dynamics of cyclic GMP synthesis in retinal rods.Neuron. 2002; 36 (12367508): 81-91
- Adaptation in vertebrate photoreceptors.Physiol. Rev. 2001; 81 (11152756): 117-151
- Electrogenic Na-Ca exchange in retinal rod outer segment.Nature. 1984; 311 (6434995): 661-663
- A new mouse model for stationary night blindness with mutant Slc24a1 explains the pathophysiology of the associated human disease.Hum. Mol. Genet. 2015; 24 (26246500): 5915-5929
- The Na+/Ca2+, K+ exchanger NCKX4 is required for efficient cone-mediated vision.Elife. 2017; 6 (28650316): e24550
- The Na+/Ca2+, K+ exchanger 2 modulates mammalian cone phototransduction.Sci. Rep. 2016; 6 (27580676): 32521
- Guanylyl cyclase-activating proteins (GCAPs) are Ca2+/Mg2+ sensors: implications for photoreceptor guanylyl cyclase (RetGC) regulation in mammalian photoreceptors.J. Biol. Chem. 2004; 279 (14993224): 16903-16906
- Enzymatic relay mechanism stimulates cyclic GMP synthesis in rod photoresponse: biochemical and physiological study in guanylyl cyclase activating protein 1 knockout mice.PLoS One. 2012; 7 (23082185): e47637
- Enzymatic properties and regulation of the native isozymes of retinal membrane guanylyl cyclase (RetGC) from mouse photoreceptors.Biochemistry. 2011; 50 (21598940): 5590-5600
- Regulatory modes of rod outer segment membrane guanylate cyclase differ in catalytic efficiency and Ca2+-sensitivity.Eur. J. Biochem. 2003; 270 (12950265): 3814-3821
- cGMP accumulation causes photoreceptor degeneration in CNG channel deficiency: evidence of cGMP cytotoxicity independently of enhanced CNG channel function.J. Neurosci. 2013; 33 (24027293): 14939-14948
- Gene therapy fully restores vision to the all-cone Nrl(−/−) Gucy2e(−/−) mouse model of Leber congenital amaurosis-1.Hum. Gene Ther. 2015; 26 (26247368): 575-592
- Localization of guanylate cyclase-activating protein 2 in mammalian retinas.Proc. Natl. Acad. Sci. U.S.A. 1997; 94 (9114059): 4727-4732
- Induction of the unfolded protein response by constitutive G-protein signaling in rod photoreceptor cells.J. Biol. Chem. 2014; 289 (25183010): 29310-29321
- Role of guanylyl cyclase modulation in mouse cone phototransduction.J. Neurosci. 2011; 31 (21632921): 7991-8000
- Disruption of a retinal guanylyl cyclase gene leads to cone-specific dystrophy and paradoxical rod behavior.J. Neurosci. 1999; 19 (10407028): 5889-5897
- Free magnesium concentration in salamander photoreceptor outer segments.J. Physiol. 2003; 553 (14500766): 125-135
- Identification of target binding site in photoreceptor guanylyl cyclase-activating protein 1 (GCAP1).J. Biol. Chem. 2014; 289 (24567338): 10140-10154
- Evaluating the role of retinal membrane guanylyl cyclase 1 (RetGC1) domains in binding guanylyl cyclase-activating proteins (GCAPs).J. Biol. Chem. 2015; 290 (25616661): 6913-6924
- Induction by cyclic GMP of cationic conductance in plasma membrane of retinal rod outer segment.Nature. 1985; 313 (2578616): 310-313
- Cyclic GMP-sensitive conductance in outer segment membrane of catfish cones.Nature. 1985; 317 (2993914): 61-64
- A novel Ca2+-feedback mechanism extends the operating range of mammalian rods to brighter light.J. Gen. Physiol. 2015; 146 (26415569): 307-321
- Electrical and adaptive properties of rod photoreceptors in Bufo marinus. I. Effects of altered extracellular Ca2+ levels.J. Gen. Physiol. 1977; 70 (412914): 747-770
- The effects of low calcium and background light on the sensitivity of toad rods.J. Physiol. 1982; 330 (6816919): 307-329
- Effects of lowered cytoplasmic calcium concentration and light on the responses of salamander rod photoreceptors.J. Physiol. 1995; 484 (7541466): 267-286
- Effect of ions on the light-sensitive current in retinal rods.Nature. 1981; 292 (6265800): 502-505
- Measurement of cytoplasmic calcium concentration in the rods of wild-type and transducin knock-out mice.J. Physiol. 2002; 542 (12154183): 843-854
- Retinal guanylyl cyclase isozyme 1 is the preferential in vivo target for constitutively active GCAP1 mutants causing congenital degeneration of photoreceptors.J. Neurosci. 2012; 32 (22623665): 7208-7217
- Rhodopsin expression level affects rod outer segment morphology and photoresponse kinetics.PLoS One. 2012; 7 (22662234): e37832
- A role for GCAP2 in regulating the photoresponse. Guanylyl cyclase activation and rod electrophysiology in GUCA1B knock-out mice.J. Biol. Chem. 2008; 283 (18723510): 29135-29143
- Phototransduction in transgenic mice after targeted deletion of the rod transducin α-subunit.Proc. Natl. Acad. Sci. U.S.A. 2000; 97 (11095744): 13913-13918
- Mouse cone arrestin expression pattern: light induced translocation in cone photoreceptors.Mol. Vis. 2002; 8 (12486395): 462-471
- Ex vivo ERG analysis of photoreceptors using an in vivo ERG system.Vision Res. 2014; 101 (24959652): 108-117
- Functionally rodless mice: transgenic models for the investigation of cone function in retinal disease and therapy.Vision Res. 2002; 42 (11853756): 401-415
- Intra-retinal visual cycle required for rapid and complete cone dark adaptation.Nat. Neurosci. 2009; 12 (19182795): 295-302
- Calcium sets the physiological value of the dominant time constant of saturated mouse rod photoresponse recovery.PLoS One. 2010; 5 (20885958): e13025
- Spatiotemporal cGMP dynamics in living mouse rods.Biophys. J. 2012; 102 (22768933): 1775-1784
- A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors.J. Physiol. 1992; 449 (1326052): 719-758
- Calcium binding, but not a calcium-myristoyl switch, controls the ability of guanylyl cyclase-activating protein GCAP-2 to regulate photoreceptor guanylyl cyclase.J. Biol. Chem. 1997; 272 (9162068): 14327-14333
- Ca2+ and Mg2+ binding properties of GCAP-1. Evidence that Mg2+-bound form is the physiological activator of photoreceptor guanylyl cyclase.J. Biol. Chem. 2006; 281 (16793776): 23830-23841
Article info
Publication history
Footnotes
This work was supported by National Institutes of Health Grants EY026651 (to F. V.), EY019312 (to V. J. K.), EY027387 (to V. J. K. and J. C.), EY012155 and EY027193 (to J. C.), EY011522 (to A. M. D.), and EY02687 (to Washington University, Department Ophthalmology); Research to Prevent Blindness; and the Ella and Georg Ehrnrooth Foundation (to F. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Identification
Copyright
User license
Creative Commons Attribution (CC BY 4.0) |
Permitted
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
Elsevier's open access license policy